Equities
Health CareMedical Equipment and Services
  • Price (USD)139.01
  • Today's Change0.66 / 0.48%
  • Shares traded1.39m
  • 1 Year change+23.36%
  • Beta1.0564
Data delayed at least 15 minutes, as of Sep 19 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy4
Outperform4
Hold12
Sell1
Strong Sell0

Share price forecast in USD

The 16 analysts offering 12 month price targets for Agilent Technologies Inc have a median target of 147.00, with a high estimate of 165.00 and a low estimate of 130.00. The median estimate represents a 5.75% increase from the last price of 139.01.
High18.7%165.00
Med5.7%147.00
Low-6.5%130.00

Dividends in USD

In 2023, Agilent Technologies Inc reported a dividend of 0.89 USD, which represents a 7.40% increase over last year. The 10 analysts covering the company expect dividends of 0.94 USD for the upcoming fiscal year, an increase of 5.76%.
Div growth (TTM)7.40%
More ▼

Earnings history & estimates in USD

On Aug 21, 2024, Agilent Technologies Inc reported 3rd quarter 2024 earnings of 1.32 per share. This result exceeded the 1.26 consensus of the 16 analysts covering the company and under-performed last year's 3rd quarter results by 7.69%.
The next earnings announcement is expected on Nov 18, 2024.
Average growth rate-1.81%
Agilent Technologies Inc reported annual 2023 earnings of 5.44 per share on Nov 20, 2023.
Average growth rate+15.57%
More ▼

Revenue history & estimates in USD

Agilent Technologies, Inc. had 3rd quarter 2024 revenues of 1.58bn. This bettered the 1.56bn consensus of the 14 analysts covering the company. This was 10.14% below the prior year's 3rd quarter results.
Average growth rate-1.41%
Agilent Technologies, Inc. had revenues for the full year 2023 of 6.83bn. This was 0.22% below the prior year's results.
Average growth rate+7.48%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.